Literature DB >> 22262602

A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data.

Leonardo Tamariz1, Thomas Harkins, Vinit Nair.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) is a serious complication. Large claims databases can potentially identify the effects that medications have on VTE. The purpose of this study is to evaluate the evidence supporting the validity of VTE codes.
METHODS: A search of MEDLINE database is supplemented by manual searches of bibliographies of key relevant articles. We selected all studies in which a claim code was validated against a medical record. We reported the positive predictive value (PPV) for the VTE claim compared to the medical record.
RESULTS: Our search strategy yielded 345 studies, of which only 19 met our eligibility criteria. All of the studies reported on ICD-9 codes, but only two studies reported on pharmacy codes, and one study reported on procedure codes. The highest PPV (65%-95%) was reported for the combined use of ICD-9 codes 415 (pulmonary embolism), 451, and 453 (deep vein thrombosis) as a VTE event. If a specific event like DVT (PPV 24%-92%) or PE (PPV 31%-97%) was evaluated, the PPV was lower than when the combined events were examined. Studies that included patients after orthopedic surgery reported the highest PPV (96%-100%).
CONCLUSIONS: The use of ICD-9 415, 451, and 453 are appropriate for the identification of VTE in claims databases. The codes performed best when codes were evaluated in patients at higher risk of VTE.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22262602     DOI: 10.1002/pds.2341

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  65 in total

1.  Clinical and financial impact of HACs: a commentary on clinical and financial costs of hospital-acquired conditions.

Authors:  Brian Branchford
Journal:  Transl Pediatr       Date:  2015-10

2.  Using multiple sources of data for surveillance of postoperative venous thromboembolism among surgical patients treated in Department of Veterans Affairs hospitals, 2005-2010.

Authors:  Richard E Nelson; Scott D Grosse; Norman J Waitzman; Junji Lin; Scott L DuVall; Olga Patterson; James Tsai; Nimia Reyes
Journal:  Thromb Res       Date:  2015-01-26       Impact factor: 3.944

3.  Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.

Authors:  Christine Baumgartner; Judith Maselli; Andrew D Auerbach; Margaret C Fang
Journal:  J Gen Intern Med       Date:  2019-06-24       Impact factor: 5.128

4.  Design and Implementation of a Comprehensive Surveillance System for Venous Thromboembolism in a Defined Region Using Electronic and Manual Approaches.

Authors:  Thomas L Ortel; Katie Arnold; Michele Beckman; Audrey Brown; Nimia Reyes; Ibrahim Saber; Ryan Schulteis; Bhavana Pendurthi Singh; Andrea Sitlinger; Elizabeth H Thames
Journal:  Appl Clin Inform       Date:  2019-07-31       Impact factor: 2.342

5.  Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.

Authors:  Kathleen M Mortimer; Dorothee B Bartels; Nadine Hartmann; Jorge Capapey; Jing Yang; Robert Gately; Cheryl Enger
Journal:  Respiration       Date:  2020-01-24       Impact factor: 3.580

6.  Comparative risk of incident venous thromboembolism in patients with inflammatory bowel disease initiating tumour necrosis factor-α inhibitors or nonbiologic agents: a cohort study.

Authors:  Rishi J Desai; Joshua J Gagne; Joyce Lii; Jun Liu; Sonia Friedman; Seoyoung C Kim
Journal:  CMAJ       Date:  2017-11-27       Impact factor: 8.262

7.  Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.

Authors:  Hussain R Yusuf; W Craig Hooper; Scott D Grosse; Christopher S Parker; Sheree L Boulet; Thomas L Ortel
Journal:  Thromb Res       Date:  2014-10-22       Impact factor: 3.944

8.  Identifying Patients With High Data Completeness to Improve Validity of Comparative Effectiveness Research in Electronic Health Records Data.

Authors:  Kueiyu Joshua Lin; Daniel E Singer; Robert J Glynn; Shawn N Murphy; Joyce Lii; Sebastian Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2017-10-10       Impact factor: 6.875

9.  The design and implementation of a new surveillance system for venous thromboembolism using combined active and passive methods.

Authors:  Aaron M Wendelboe; Janis Campbell; Micah McCumber; Dale Bratzler; Kai Ding; Michele Beckman; Nimia Reyes; Gary Raskob
Journal:  Am Heart J       Date:  2015-06-11       Impact factor: 4.749

10.  National trends and outcomes for extra-corporeal membrane oxygenation use in high-risk pulmonary embolism.

Authors:  Ayman Elbadawi; Amgad Mentias; Islam Y Elgendy; Ahmed H Mohamed; Mohammed Hz Syed; Gbolahan O Ogunbayo; Odunayo Olorunfemi; Igor Gosev; Sunil Prasad; Scott J Cameron
Journal:  Vasc Med       Date:  2019-03-05       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.